Low Cholesterol Diet Meals

In a fascinating broadcast on National Public Radio, internationally renowned medicinal mushroom expert Paul Stamets tells his story of discovering the medicinal potential of agarikon, an extremely rare and threatened species of wood conk that requires century-old trees to grow. Agarikon is today all but extinct in Europe, its remaining distribution limited to the old growth forests on the North American West Coast.

Stamets knew that fungi (mushrooms) were more closely related to humans than to plants and therefore susceptible to many of the same pathogens (bacteria, molds, viruses). And yet the perennial agarikon mushroom managed to remain disease free in the dripping wet rainforests for up to 50 years without decaying from rot, mold, or bacteria. So therefore it followed, he figured, that it must possess a powerful immune system full of antibiotic compounds that might benefit people.

Agarikon in the wild looks somewhat like a beehive on the trunk of some of the giant, ancient trees of the old-growth forests of the American northwest. (See picture of Paul Stamets with one of these wood conks by clicking on the agarikon-link on this page.) Be aware that this is an endangered species, which should be left unharmed in the wild. But be sure to bring your digital camera so you can prove to your mushroom club friends that you saw it.

Paul Stamets now grows his own agarikon, which he uses for his agarikon extract. A sample of this extract was sent to the BIO Shield Program for testing at a top security lab located in Ft. Dietrich, MD. The BIO Shield Program is a division within the Defense Department created to search for remedies against biological warfare agents and bioterrorism threats – e.g. pathogens like smallpox or anthrax.

Several tens of thousands of natural and synthetic “medicines” have been tested within the Bio Shield Program. According to John Seacrest, drug discovery supervisor within BIO Shield, the agarikon extract submitted by Paul Stamets was one of only a few agents that tested positive against viruses related to smallpox. While smallpox virus itself is not available for testing (due to it being supposedly extinct and all), the agarikon extract proved effective in inhibiting closely related viruses (presumably cowpox).

In lieu of this discovery, Stamets has applied for a patent to a mushroom related anti-viral drug. One of his sponsors is Boston investor John Norris. As Mr. Norris so correctly points out, not everybody is willing or able to be vaccinated.

It’s also worth mentioning that Mr. Norris is a former second in command in the FDA hierarchy, and he believes that through his joint venture with Paul Stamets, they could soon be selling several hundred million doses of the Stamets agarikon extract to the armies of the United States, U.K., and Germany.

That may still be a few years into the future, though. Paul Stamets new mushroom related anti-viral medicine first has to stand up to exhaustive testing, and then eventually be approved for release by the FDA.

Note: The above article is intended for informational purposes only. Agarikon has not been approved by the FDA for use as a medicinal. Never use any herbal or mushroom-product for medicinal purposes unless advice to do so by a licensed medical practitioner.

Reference: NPR Morning Edition, Smallpox Defense May Be Found in Mushrooms by Tom Banse, August 4, 2005.

About author: Dr. Markho Rafael has worked in natural health since 1996, specializing in medicinal mushrooms. Click Agarikon Mushroom for agarikon-photo, mushroom products, free mushroom articles, or to request a unique copy of any mushroom article for your own web-site or magazine / ezine. Click Fomitopsis medicinal for scientific research references about agarikon.